Brief: Wockhardt Says Foviscu Meets Main Goal In Phase 3 Trial
27/01/2026 03:32
Jan 27 (Reuters) - Wockhardt Ltd WCKH.NS: FOVISCU® MEETS MAIN GOAL IN PHASE 3 TRIAL Source text: ID:nBSE9QYxcm Further company coverage: WCKH.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter